The Scientist : VIP treatment for arthritis [2/5/2001]

Email: Tudor Toma - ttoma@mail.dntis.ro
News from The Scientist 2001, 2(1):20010502-01

2 May 2001

Rheumatoid arthritis is an autoimmune disease characterized by chronic joint inflammation and subsequent destruction of the associated cartilage and bone. In May Nature Medicine Mario Delgado and colleagues from Complutense University, Madrid show that administration of the vasoactive intestinal peptide (VIP) can modulate the mechanisms of the disease and could be the basis for a new treatment for arthritis.

Password

> Forgot Password?
> FAQ
> Subscribe

Subscribing to The Scientist is easy and inexpensive.

And you can choose from many options. Try us out with an online day pass starting at only $4.95. Or, get it all with unlimited online access to The Scientist Archive and door-to-door delivery of our monthly print magazine.


	The Scientist also offers site licenses to institutions and organizations. When your librarian adds The Scientist to the library's collection, you can get unlimited online access through your place of work or study. Recommend The Scientist today